CD4 and myeloid sarcoma: Taken into consideration, CB2R-mediated inhibition of cytokines from Th1 and Th2 cells and inhibition of CD4 migration to CNS account for the beneficial effect as well as suppressed survival of oligodendrocytes concomitantly involved in exacerbation of MS.